Written by Klarity Editorial Team
Published: Jul 12, 2026

Last updated: July 12, 2026
If you have Aetna insurance in New Mexico and you or a family member has been diagnosed with attention-deficit/hyperactivity disorder (ADHD), you likely have questions about what your plan covers, how prior authorization works, and whether telehealth prescribing is a viable option. This guide breaks down Aetna’s ADHD coverage in New Mexico for 2026, including the CVS/Caremark formulary, Electronic Prescribing of Controlled Substances (EPCS) requirements, New Mexico parity law protections, and how to work with your plan if a claim is denied.
Think your Aetna plan may cover ADHD treatment? Klarity Health connects New Mexico residents with licensed providers who accept many insurance plans. See if you may qualify for ADHD treatment through Klarity.
Coverage varies by plan. Verify your specific benefits before scheduling any appointment.
Aetna administers pharmacy benefits for most of its commercial and ACA marketplace plans in New Mexico through CVS/Caremark, one of the largest pharmacy benefit managers (PBMs) in the United States. The CVS/Caremark formulary uses a tiered structure — typically four tiers — where lower tiers carry lower out-of-pocket costs and higher tiers require step therapy or prior authorization (PA).
For ADHD specifically, the formulary generally follows a generic-first approach: generic stimulants and non-stimulants are placed in Tier 1 or Tier 2 with no PA required, while brand-name stimulants are placed in Tier 3 or Tier 4 and typically require PA, step therapy, or both. Medical ADHD coverage (office visits, telehealth consultations, diagnostic evaluations) falls under your medical benefit rather than the pharmacy benefit and is subject to your deductible, copay, and coinsurance terms.
The specific tier placement and PA requirements on your plan may differ from the general CVS/Caremark commercial formulary depending on whether your employer has customized the drug list. Always verify your benefits at aetna.com or by calling the member services number on your insurance card.
The following table reflects typical CVS/Caremark commercial formulary placement for ADHD stimulants in 2026. Verify your specific plan’s formulary for exact tier, PA requirements, and quantity limits.
| Medication | Type | Typical Tier | PA Required? | Notes |
|---|---|---|---|---|
| Amphetamine/dextroamphetamine (generic Adderall) | Mixed amphetamine salts IR | Tier 1–2 | No | Generic first-line; widely preferred |
| Mixed amphetamine salts ER (generic Adderall XR) | Extended-release stimulant | Tier 2 | No | Generic ER; no PA on most commercial plans |
| Methylphenidate IR (generic Ritalin) | Methylphenidate IR | Tier 1–2 | No | Generic first-line |
| Methylphenidate ER (generic Concerta/Metadate CD) | Methylphenidate ER | Tier 1–2 | No | Generic ER; no PA on most commercial plans |
| Dextroamphetamine (generic Dexedrine) | Dextroamphetamine | Tier 1–2 | No | Generic; less commonly prescribed as first-line |
| Lisdexamfetamine (generic Vyvanse) | Prodrug amphetamine | Tier 2–3 | Verify with plan | Generic lisdexamfetamine now available; tier placement varies by plan — verify before dispensing |
| Adderall XR (brand) | Mixed amphetamine salts ER | Tier 3–4 | Yes | Brand; step therapy through generic typically required |
| Vyvanse (brand lisdexamfetamine) | Prodrug amphetamine | Tier 3–4 | Yes | Brand; generic lisdexamfetamine now available — CVS/Caremark may require generic step |
| Concerta (brand methylphenidate ER) | Methylphenidate ER | Tier 3–4 | Yes | Brand; generic step required on most plans |
| Focalin XR (brand dexmethylphenidate) | Dexmethylphenidate ER | Tier 3–4 | Yes | Brand; PA required |
| Mydayis (amphetamine salts ER) | Extended-release stimulant | Tier 3–4 | Yes | PA required; for adults only |
| Jornay PM (methylphenidate ER) | Evening-dosed stimulant | Tier 3–4 | Yes | PA required; novel formulation |
All stimulants listed above are DEA Schedule II controlled substances. See the EPCS section below for New Mexico prescribing requirements.
| Medication | Class | Typical Tier | PA Required? | Notes |
|---|---|---|---|---|
| Atomoxetine (generic Strattera) | SNRI/NRI | Tier 2–3 | No (generic) | Generic widely available; non-controlled; suitable for patients who cannot take stimulants |
| Strattera (brand) | SNRI/NRI | Tier 3–4 | Yes | Brand requires step through generic atomoxetine |
| Guanfacine ER (generic Intuniv) | Alpha-2 agonist | Tier 1–2 | No | Generic; used as monotherapy or adjunct |
| Intuniv (brand guanfacine ER) | Alpha-2 agonist | Tier 3–4 | Yes | Step through generic required on most plans |
| Clonidine ER (generic Kapvay) | Alpha-2 agonist | Tier 1–2 | No | Generic; adjunct or monotherapy |
| Kapvay (brand clonidine ER) | Alpha-2 agonist | Tier 3–4 | Yes | Step through generic required |
| Qelbree (viloxazine ER) | SNRI | Tier 3–4 | Yes | Brand-only; non-controlled; PA required; no generic available |
| Wellbutrin/bupropion (off-label) | NDRI antidepressant | Tier 1–2 | No | Generic; off-label for ADHD; non-controlled |
For brand-name stimulants and some non-stimulants, Aetna and CVS/Caremark typically require prior authorization. The PA process for ADHD medications generally requires:
PA request timelines under federal law are 72 hours for standard requests and 24 hours for urgent/expedited requests. If Aetna denies a PA, you have the right to appeal internally and, if the internal appeal is unsuccessful, to request an external independent review through the New Mexico Office of Superintendent of Insurance (OSI).
To initiate a PA or check the status of a pending request, call CVS/Caremark at 1-800-552-8159 or log in to your Aetna member portal.
New Mexico requires Electronic Prescribing of Controlled Substances (EPCS) for Schedule II medications under state law. Because all stimulant ADHD medications (amphetamine salts, methylphenidate, lisdexamfetamine, dexmethylphenidate) are DEA Schedule II controlled substances, prescribers in New Mexico must transmit these prescriptions electronically to a pharmacy that accepts EPCS. Paper prescriptions for Schedule II medications are no longer the standard practice in New Mexico.
What this means for patients seeking ADHD treatment through telehealth: the prescribing provider must use a EPCS-compliant platform, and the dispensing pharmacy must accept electronic Schedule II prescriptions. Most major chain pharmacies and many independent pharmacies are EPCS-enabled. When scheduling a telehealth ADHD appointment, confirm that the provider’s platform supports EPCS — Klarity Health providers use EPCS-compliant systems for all Schedule II prescriptions.
Non-stimulant ADHD medications — atomoxetine, guanfacine ER, clonidine ER, viloxazine (Qelbree), and off-label bupropion — are not controlled substances and are not subject to EPCS requirements. These may be prescribed through standard telehealth workflows without additional prescribing infrastructure.
New Mexico’s mental health parity law (NMSA 1978 § 59A-23E-19 et seq.) requires that commercial insurers offering coverage for mental health and substance use disorder (MH/SUD) conditions provide benefits that are no more restrictive than benefits for comparable medical and surgical conditions. ADHD is a recognized mental health condition under the DSM-5 and is covered by parity protections.
In practice, parity means that Aetna may not impose higher copays, stricter PA requirements, more frequent step therapy, or lower visit limits for ADHD treatment than it does for analogous medical conditions. If you believe a claim denial or coverage restriction violates parity requirements, you can file a complaint with the New Mexico Office of Superintendent of Insurance (OSI) at 1-855-427-5674.
Important exception: If your employer provides coverage through a self-funded ERISA plan, New Mexico’s state parity statute does not apply directly. Self-funded employer plans are governed by federal law — the Mental Health Parity and Addiction Equity Act (MHPAEA) — rather than by state insurance regulations. The federal parity framework provides similar protections, but complaints about self-funded ERISA plans are directed to the U.S. Department of Labor rather than NM OSI.
To determine whether your plan is fully insured (state law applies) or self-funded (federal law applies), check your Summary Plan Description or call the member services number on your insurance card.
If Aetna denies coverage for an ADHD medication or service, you have a structured appeal process:
Your Aetna Explanation of Benefits (EOB) will include the specific clinical or administrative reason for the denial, which should be referenced in your appeal.
Aetna’s telehealth coverage for mental health services in New Mexico may include ADHD evaluations, medication management visits, and follow-up appointments conducted via video or phone with a licensed provider. Under New Mexico’s telehealth parity provisions, Aetna-insured patients may be entitled to the same level of coverage for a telehealth mental health visit as for an equivalent in-person visit.
Klarity Health has 2,000+ licensed providers across the United States, including providers licensed in New Mexico who accept a wide range of insurance plans. If your Aetna plan provides in-network or out-of-network mental health benefits, a Klarity provider may be able to conduct your ADHD evaluation and, if clinically appropriate, submit an EPCS prescription electronically to your preferred pharmacy.
Ready to explore ADHD treatment options? Check if your Aetna plan may cover treatment through Klarity Health.
Aetna plans in New Mexico typically cover ADHD medications through the CVS/Caremark pharmacy benefit. Generic stimulants and non-stimulants are usually placed in Tier 1–2 with no prior authorization required. Brand-name medications are generally Tier 3–4 and may require PA and step therapy through a generic equivalent. Coverage varies by specific plan — verify your formulary at aetna.com or call 1-800-872-3862.
Brand Vyvanse and Adderall XR are typically Tier 3–4 on CVS/Caremark formularies and may require prior authorization. Generic lisdexamfetamine (the Vyvanse generic) and generic mixed amphetamine salts ER (the Adderall XR generic) are typically available at lower tiers with no PA requirement. If your provider believes the brand is medically necessary after a generic trial, they can submit a PA request on your behalf. Verify current formulary placement before dispensing, as tier positions may change throughout the year.
Yes. New Mexico requires Electronic Prescribing of Controlled Substances for all Schedule II medications, including all stimulant ADHD medications (amphetamine salts, methylphenidate, lisdexamfetamine, dexmethylphenidate). Your telehealth or in-person prescriber must use an EPCS-compliant platform, and your pharmacy must accept electronic Schedule II prescriptions. Non-stimulant ADHD medications (atomoxetine, guanfacine ER, clonidine ER, viloxazine) are not controlled substances and are not subject to EPCS requirements.
If your Aetna plan is a fully insured commercial or ACA marketplace plan, New Mexico’s mental health parity law (NMSA 1978 § 59A-23E-19 et seq.) applies. Aetna may not impose more restrictive coverage terms for ADHD than for comparable medical conditions. If your plan is a self-funded employer plan, federal MHPAEA parity protections apply instead. Contact NM OSI at 1-855-427-5674 for fully insured plan parity complaints, or the U.S. Department of Labor for self-funded ERISA plan complaints.
Many Aetna plans in New Mexico may cover telehealth mental health and ADHD services. Klarity Health connects New Mexico residents with licensed telehealth providers who accept a wide range of insurance plans. Coverage depends on your specific plan’s in-network and out-of-network benefit structure. Verify your telehealth mental health benefits before booking, and confirm the provider is in-network if in-network cost-sharing applies to your plan.
Disclaimer: This guide is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage terms, formulary positions, and prior authorization requirements vary by specific plan and may change throughout the year. Always verify your benefits directly with Aetna and CVS/Caremark before scheduling treatment or filling a prescription. Klarity Health is not affiliated with Aetna or CVS/Caremark.
Explore ADHD treatment with Klarity Health. Our licensed New Mexico providers may be covered by your Aetna plan. Check if you may qualify today.
Find the right provider for your needs — select your state to find expert care near you.